Merck & Co., Inc. (MRK)
| Market Cap | 193.12B |
| Revenue (ttm) | 48.02B |
| Net Income (ttm) | 7.03B |
| Shares Out | 2.53B |
| EPS (ttm) | 2.77 |
| PE Ratio | 27.54 |
| Forward PE | 12.06 |
| Dividend | $2.48 |
| Dividend Yield | 3.25% |
| Trading Day | June 11 |
| Last Price | $76.27 |
| Previous Close | $76.14 |
| Change ($) | 0.13 |
| Change (%) | 0.17% |
| Day's Open | 76.58 |
| Day's Range | 75.60 - 76.86 |
| Day's Volume | 13,928,356 |
| 52-Week Range | 15.32 - 85.73 |
Final Trades: Allscripts, Kinder Morgan, Merck & more
The "Halftime Report" traders give their top picks to watch for the second half.
It is hard to believe, but in just over three weeks the second quarter will come to a close and many investors will be reviewing their portfolios and making changes for the second half of 2021.
Merck (MRK) is set to supply 1.7 million courses of its oral COVID-19 therapy candidate, molnupiravir, worth $1.2 billion to the U.S. government, following a potential approval or authorization.
Attractive dividends plus strong growth? Yes, please.
The U.S. government will pay $1.2 billion for 1.7 billion doses of Merck's experimental oral COVID-19 drug.
Merck & Co Inc (NYSE: MRK) has entered into a procurement agreement with the U.S. government for molnupiravir (MK-4482), an antiviral candidate for mild to moderate COVID-19. Molnupiravir is currently b...
Merck to supply U.S. government with oral antiviral drug used to treat Covid
Merck will supply an oral antiviral medication intended to treat mild to moderate Covid-19 to the U.S. government in a new procurement agreement. CNBC's Meg Tirrell reports.
KENILWORTH, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Announces Supply Agreement with U.S. Government for Molnupiravir
In the latest trading session, Merck (MRK) closed at $72.80, marking a -1.77% move from the previous day.
MADISON, N.J.--(BUSINESS WIRE)--MSD Animal Health to Acquire Assets of LIC Automation Ltd.
Merck & Co Inc (NYSE: MRK) has announced new data from Phase 3 CLEAR (Study 307)/KEYNOTE-581 trial, which evaluated the combinations of Keytruda (pembrolizumab) plus Lenvima from Eisai Co Ltd (OTC: ESAL...
KENILWORTH, N.J., & WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)---- $MRK #MRK--New Data on KEYTRUDA® Plus LENVIMA® Versus Sunitinib in First-Line Treatment for Patients With Advanced Renal Cell Carcinoma
AstraZeneca Plc (NASDAQ: AZN) and Merck & Co Inc (NYSE: MRK) have announced the first presentation of data from the Phase 3 OlympiA trial evaluating Lynparza (olaparib) in a subset of early breast cance...
Merck & Co (NYSE: MRK) announced first-time results from the pivotal Phase 3 KEYNOTE-564 trial evaluating Keytruda for the potential adjuvant treatment in a subset of patients with renal cell carcinoma ...
KENILWORTH, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck's KEYTRUDA Given After Surgery Reduced Risk of Disease Recurrence or Death 32% vs Placebo as Adj Therapy in Patients with Renal Cell Carcinoma
KENILWORTH, N.J.--(BUSINESS WIRE)---- $MRK #MRK--LYNPARZA Reduced Risk of Invasive Disease Recurrence or Death 42% vs Placebo in Adj Treatment of BRCA Mutated HER2-Neg Early Breast Cancer
In a move to free up a cash windfall and streamline the business, Merck & Co Inc (NYSE: MRK) had long planned to slice away its women's health business into a standalone spinoff. As of Thursday, that sp...
KENILWORTH, N.J.--(BUSINESS WIRE)---- $MRK #merck--Merck Announces Completion of Organon & Co. Spinoff
The Merck spinoff Organon will likely do quite well. OGN stock is likely to be worth $52.77, or 48% above the when-issued price right now.
With solid fundamental metrics, these defensive stocks deserve your attention now The post 7 Best Stocks To Buy To Hedge Against A Potential Downturn appeared first on InvestorPlace. More From InvestorP...
Sutro Biopharma Receives Undisclosed Milestone Payment Under Bispecific ADC Collaboration with Merck
Sutro Biopharma Inc (NASDAQ: STRO) has received a milestone payment under its collaboration and license agreement with the healthcare division of Merck KGaA Germany (OTC: MKGAF). The payment is related ...
Immutep Limited (NASDAQ: IMMP) has announced a new collaboration and supply agreement with Germany-based Merck KGaA (OTC: MKGAF) for a Phase 1/2a INSIGHT-005 trial in patients with solid tumors. The tri...
KENILWORTH, N.J. & BRIDGEWATER, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck and Sanofi's First and Only Six-in-One Pediatric Combination Vaccine Now Available in the United States
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Merck (MRK) have what it takes?
A first-of-its-kind medical device from a top-10 biotech could change medical cannabis consumption.
NEW YORK, May 27, 2021 /PRNewswire/ -- Organon & Co. (NYSE: OGN) will be added to the S&P 500 prior to the open of trading on Thursday, June 3, replacing HollyFrontier, which will be removed from the S&...
Warren Buffett is a legendary investor, but he's wrong to pare down these top-tier stocks.
KENILWORTH, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Announces Third-Quarter 2021 Dividend
The CHMP recommends approval of Merck's (MRK) anti-PD-1 therapy, Keytruda in combination with chemotherapy for the first-line treatment of esophageal and gastroesophageal junction carcinoma in Europe.
Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval for Merck & Co Inc's (NYSE: MRK) Keytruda (pembrolizumab...
When the operating income margin keeps on expanding, it means that the company is maintaining the costs of goods sold and other operating expenses under predetermined limits while net sales are growing.
TOTAL (TOT) signs a 10-year deal with Merck to sell clean energy to the latter. TOTAL is working to scale up renewable energy generation capability by adding new wind and solar assets.
KENILWORTH, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Receives Positive CHMP Opinion for KEYTRUDA in Combination With Chemotherapy as First-Line Treatment for Certain Patients With Esophageal Cancer
The Oracle of Omaha likely hasn't lost a minute of sleep over these stocks.
Merck's (MRK) 15-valent pneumococcal conjugate vaccine candidate, V114, demonstrates comparable immunogenicity and safety compared to a lower valency vaccine in infants and children.
Oncolytics Biotech Inc (NASDAQ: ONCY) has announced new data from Phase 2 trial evaluating pelareorep in combination with Merck & Co Inc (NYSE: MRK) Keytruda (pembrolizumab) in pancreatic cancer. Data w...
With the trading day almost halfway over, the markets had made a handy recovery on Thursday, bouncing off the lows of last week.
Merck & Co Inc's (NYSE: MRK) investigational 15-valent pneumococcal conjugate vaccine, V114, has met its primary immunogenicity and safety endpoints in two Phase 3 pediatric programs. Full results from ...
KENILWORTH, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Announces Positive Topline Results Phase 3 Pediatric Studies for V114, Merck's Investigational 15-valent Pneumococcal Conjugate Vaccine
Older investors typically rely on income-producing investments to fund their golden years. These prospects offer a healthy balance of dividends, growth, and reliability.
Pharmaceutical stocks may come under increased pressure thanks to corporate tax increases proposed by President Joe Biden. This comes on top of the threat of federal drug price controls, according to an...
Berkshire Hathaway cuts stakes in Wells Fargo, Chevron and Merck
CNBC's Leslie Picker reports on some big moves Berkshire Hathaway made this past quarter.
WASHINGTON and KENILWORTH, N.J., May 17, 2021 /PRNewswire/ -- Vaccinate Your Family, in collaboration with Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today the launc...
Even the Oracle of Omaha is staring at some unrealized losses in his investment portfolio.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Merck (MRK) have what it takes?
Physiomics PLC (LON:PYC) jumped 11% to 6.65p in the early afternoon on the back of a further contract with German giant Merck. The consultancy said this contract is additional to the initial tranche of ...
These two companies should be on your radar.
KENILWORTH, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Announces Phase 3 KEYNOTE-522 Trial Met Dual Primary Endpoint of Event-Free Survival in Patients With Early-Stage Triple-Negative Breast Cancer
About MRK
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health segments. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, diabetes, and women's health, as well as vaccine products. The Animal Health segment provides discovers, develops, manufactures, and markets a range of veterinary pharmaceuticals, vaccines, and health management solutions and services, as we... [Read more...]
| Industry Drug Manufacturers-General | Founded 2000 |
| CEO Kenneth Frazier | Employees 73,000 |
| Stock Exchange NYSE | Ticker Symbol MRK |
Financial Performance
In 2020, Merck's revenue was $47.99 billion, an increase of 2.46% compared to the previous year's $46.84 billion. Earnings were $7.07 billion, a decrease of -28.20%.
Analyst Forecasts
According to 23 analysts, the average rating for Merck stock is "Buy." The 12-month stock price forecast is 92.89, which is an increase of 21.79% from the latest price.